Back

Gene Cluster Expression Index (GCEI) and Potential Indications for Targeted Therapy and Immunotherapy

2023-06-19 oncology Title + abstract only
View on medRxiv
Show abstract

Lung cancer recurrence risk was demonstrated to be related to driver gene and immunotherapy target gene cluster expression abnormality. Nine clusters seeded with driver genes ALK, BRAF, EGFR, MET, NTRK, RAS, RET, ROS1, TP53 and two immunotherapy target genes PDCD1 and CTLA4 were investigated respectively to predict lung cancer recurrence. The cluster of a seed was pre-selected to include fusion partner genes in the case of gene fusion, ligands, its pseudogenes, upstream and downstream co-express...

Predicted journal destinations